Suppr超能文献

大麻素CB(1)配体对离体豚鼠回肠蠕动的调节作用

Modulation of peristalsis by cannabinoid CB(1) ligands in the isolated guinea-pig ileum.

作者信息

Izzo A A, Mascolo N, Tonini M, Capasso F

机构信息

Department of Experimental Pharmacology, University of Naples 'Federico II', via D. Montesano 49, 80131 Naples, Italy.

出版信息

Br J Pharmacol. 2000 Mar;129(5):984-90. doi: 10.1038/sj.bjp.0703116.

Abstract

The effect of cannabinoid drugs on peristalsis in the guinea-pig ileum was studied. Peristalsis was induced by delivering fluid into the oral end of an isolated intestinal segment. Longitudinal muscle reflex contraction, threshold pressure and threshold volume to trigger peristalsis, compliance of the intestinal wall during the preparatory phase (a reflection of the resistance of the wall to distension) and maximal ejection pressure during the emptying phase of peristalsis were measured. The cannabinoid agonists WIN 55,212-2 (0.3 - 300 nM) and CP55,940 (0.3 - 300 nM) significantly decreased longitudinal muscle reflex contraction, compliance and maximal ejection pressure, while increased threshold pressure and volume to elicit peristalsis. These effects were not modified by the opioid antagonist naloxone (1 microM) and by the alpha-adrenoceptor antagonist phentolamine (1 microM). The inhibitory effect of both WIN 55,212-2 and CP55,940 on intestinal peristalsis was antagonized by the cannabinoid CB(1) receptor antagonist SR141716A (0.1 microM), but not by the cannabinoid CB(2) receptor antagonist SR144528 (0.1 microM). In absence of other drugs, the CB(1) receptor antagonists SR141716A (0.01 - 1 microM) and AM281 (0.01 - 1 microM) slightly (approximatively 20%) but significantly increased maximal ejection pressure during the empty phase of peristalsis without modifying longitudinal muscle reflex contraction, threshold pressure, threshold volume to trigger peristalsis and compliance. It is concluded that activation of CB(1) receptors reduces peristalsis efficiency in the isolated guinea-pig, and that the emptying phase of peristalsis could be tonically inhibited by the endogenous cannabinoid system.

摘要

研究了大麻素类药物对豚鼠回肠蠕动的影响。通过向离体肠段的口腔端注入液体来诱发蠕动。测量了纵向肌反射收缩、触发蠕动的阈压力和阈体积、准备阶段肠壁的顺应性(反映肠壁对扩张的阻力)以及蠕动排空阶段的最大喷射压力。大麻素激动剂WIN 55,212-2(0.3 - 300 nM)和CP55,940(0.3 - 300 nM)显著降低纵向肌反射收缩、顺应性和最大喷射压力,同时增加触发蠕动的阈压力和阈体积。这些作用不受阿片类拮抗剂纳洛酮(1 microM)和α-肾上腺素能受体拮抗剂酚妥拉明(1 microM)的影响。WIN 55,212-2和CP55,940对肠道蠕动的抑制作用被大麻素CB(1)受体拮抗剂SR141716A(0.1 microM)拮抗,但未被大麻素CB(2)受体拮抗剂SR144528(0.1 microM)拮抗。在无其他药物存在时,CB(1)受体拮抗剂SR141716A(0.01 - 1 microM)和AM281(0.01 - 1 microM)在蠕动排空阶段轻微(约20%)但显著增加最大喷射压力,而不改变纵向肌反射收缩、阈压力、触发蠕动的阈体积和顺应性。得出结论:CB(1)受体的激活降低了离体豚鼠的蠕动效率,并且蠕动的排空阶段可能受到内源性大麻素系统的紧张性抑制。

相似文献

1
Modulation of peristalsis by cannabinoid CB(1) ligands in the isolated guinea-pig ileum.
Br J Pharmacol. 2000 Mar;129(5):984-90. doi: 10.1038/sj.bjp.0703116.
3
Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine.
Br J Pharmacol. 1998 Nov;125(6):1345-51. doi: 10.1038/sj.bjp.0702204.
5
Characterization of cannabinoid modulation of sensory neurotransmission in the rat isolated mesenteric arterial bed.
J Pharmacol Exp Ther. 2004 Oct;311(1):411-9. doi: 10.1124/jpet.104.067587. Epub 2004 Jun 17.
7
Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids.
Eur J Pharmacol. 2003 Jan 1;458(1-2):207-15. doi: 10.1016/s0014-2999(02)02698-5.
10
Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain.
Naunyn Schmiedebergs Arch Pharmacol. 1999 Jun;359(6):466-70. doi: 10.1007/pl00005377.

引用本文的文献

1
Cannabinoid and Cannabinoid-Related Receptors in the Myenteric Plexus of the Porcine Ileum.
Animals (Basel). 2021 Jan 21;11(2):263. doi: 10.3390/ani11020263.
2
Endocannabinoid-related compounds in gastrointestinal diseases.
J Cell Mol Med. 2018 Feb;22(2):706-715. doi: 10.1111/jcmm.13359. Epub 2017 Oct 9.
3
Complementary Therapies in Inflammatory Bowel Diseases.
Curr Gastroenterol Rep. 2016 Dec;18(12):62. doi: 10.1007/s11894-016-0537-6.
4
Pharmacological characterization of cannabinoid receptor activity in the rat-isolated ileum myenteric plexus-longitudinal muscle preparation.
Br J Pharmacol. 2010 Apr;159(8):1608-22. doi: 10.1111/j.1476-5381.2009.00592.x. Epub 2010 Mar 5.
5
Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation.
Br J Pharmacol. 2008 Jan;153(2):263-70. doi: 10.1038/sj.bjp.0707486. Epub 2007 Oct 1.
6
Investigation on the relationship between cannabinoid CB1 and opioid receptors in gastrointestinal motility in mice.
Br J Pharmacol. 2006 Aug;148(8):1043-50. doi: 10.1038/sj.bjp.0706824. Epub 2006 Jul 17.
7
Tolerance to cannabinoid response on the myenteric plexus of guinea-pig ileum and human small intestinal strips.
Br J Pharmacol. 2006 Aug;148(8):1165-73. doi: 10.1038/sj.bjp.0706813. Epub 2006 Jun 19.

本文引用的文献

2
Reflex contractions of the longitudinal muscle coat of the isolated guinea-pig ileum.
J Physiol. 1959 May 19;146(2):369-79. doi: 10.1113/jphysiol.1959.sp006198.
3
Inhibitory effect of cannabinoid agonists on gastric emptying in the rat.
Naunyn Schmiedebergs Arch Pharmacol. 1999 Aug;360(2):221-3. doi: 10.1007/s002109900054.
5
Defaecation, intestinal fluid accumulation and motility in rodents: implications of cannabinoid CB1 receptors.
Naunyn Schmiedebergs Arch Pharmacol. 1999 Jan;359(1):65-70. doi: 10.1007/pl00005325.
6
In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum.
Br J Pharmacol. 1998 Dec;125(7):1393-5. doi: 10.1038/sj.bjp.0702190.
7
Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine.
Br J Pharmacol. 1998 Nov;125(6):1345-51. doi: 10.1038/sj.bjp.0702204.
9
Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors.
Br J Pharmacol. 1998 Jun;124(4):619-22. doi: 10.1038/sj.bjp.0701915.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验